Fatma Verit-Atmaca

Haydarpasa, Turkey

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Early-stage p53-abnormal endometrial cancer: high risk, but which treatment?

Early-stage p53-abnormal endometrial cancer: high risk, but which treatment?

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: July 13, 2026

From biological plausibility to clinical uncertainty: poly(adenosine diphosphate-ribose) polymerase-based strategies in recurrent cervical cancer.

From biological plausibility to clinical uncertainty: poly(adenosine diphosphate-ribose) polymerase-based strategies in recurrent cervical cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: May 11, 2026

From molecular insight to clinical judgment in high-intermediate-risk endometrial cancer.

From molecular insight to clinical judgment in high-intermediate-risk endometrial cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: February 08, 2026

The POLE paradox in advanced endometrial cancer: can biology replace oncologic evidence?

The POLE paradox in advanced endometrial cancer: can biology replace oncologic evidence?

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: December 14, 2025

Myoinvasion-negative but high-risk: revisiting adjuvant therapy in aggressive endometrial histotypes.

Myoinvasion-negative but high-risk: revisiting adjuvant therapy in aggressive endometrial histotypes.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: October 27, 2025

Myoinvasion-negative but high-risk: revisiting adjuvant therapy in aggressive endometrial histotypes.

Myoinvasion-negative but high-risk: revisiting adjuvant therapy in aggressive endometrial histotypes.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: October 27, 2025

Recurrent adult-type granulosa cell tumors: minimally invasive versus open cytoreductive surgery.

Recurrent adult-type granulosa cell tumors: minimally invasive versus open cytoreductive surgery.

Journal: American journal of obstetrics and gynecology
Published: September 15, 2025

Redefining surgical goals: beyond R0 for long-term survival in advanced ovarian cancer.

Redefining surgical goals: beyond R0 for long-term survival in advanced ovarian cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: August 28, 2025

Correspondence on "Cytoreductive surgery in advanced epithelial ovarian cancer: a real-world analysis guided by clinical variables, homologous recombination, and BRCA status" by Shachar et al.

Correspondence on "Cytoreductive surgery in advanced epithelial ovarian cancer: a real-world analysis guided by clinical variables, homologous recombination, and BRCA status" by Shachar et al.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: August 18, 2025

Correspondence on 'The Cukurova score in the prediction of primary cytoreduction in ovarian cancer' by Khatib et al.

Correspondence on 'The Cukurova score in the prediction of primary cytoreduction in ovarian cancer' by Khatib et al.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: March 07, 2024

Correspondence on: The risk of lymph node metastasis in the new FIGO 2018 stage IA cervical cancer with >7 mm diameter by Nicolai et al.

Correspondence on: The risk of lymph node metastasis in the new FIGO 2018 stage IA cervical cancer with >7 mm diameter by Nicolai et al.

Journal: Journal of gynecologic oncology
Published: February 25, 2024

Correspondence on 'Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors' by Musacchio et al.

Correspondence on 'Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors' by Musacchio et al.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: September 20, 2023
Showing 1-12 of 19

Last Updated: 09/26/2026